重新定义非酒精性脂肪性肝病：名称中有何含义？ - Suppr

Redefining non-alcoholic fatty liver disease: what's in a name?

出版信息

Lancet Gastroenterol Hepatol. 2020 May;5(5):419. doi: 10.1016/S2468-1253(20)30091-1.

DOI:10.1016/S2468-1253(20)30091-1

PMID:32277896

Abstract

摘要

相似文献

Redefining non-alcoholic fatty liver disease: what's in a name?

Lancet Gastroenterol Hepatol. 2020 May;5(5):419. doi: 10.1016/S2468-1253(20)30091-1.

Editorial: NAFLD, NAFLD, or MASLD: what's in a name?

Aliment Pharmacol Ther. 2024 Sep;60(5):648-649. doi: 10.1111/apt.18039.

Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease.

Hepatol Int. 2020 Jan;14(1):5-7. doi: 10.1007/s12072-019-09999-4. Epub 2019 Nov 21.

Achieving global uniformity for the new name and diagnostic criteria of non-alcoholic fatty liver disease.

J Formos Med Assoc. 2024 Jun;123(6):636-637. doi: 10.1016/j.jfma.2024.01.014. Epub 2024 Jan 13.

Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new.

Dig Liver Dis. 2018 Nov;50(11):1163-1165. doi: 10.1016/j.dld.2018.08.026. Epub 2018 Sep 1.

What's in a NAme?

Hepatology. 2009 Sep;50(3):663-7. doi: 10.1002/hep.23070.

Paediatric fatty liver disease (PeFLD): All is not NAFLD - Pathophysiological insights and approach to management.

J Hepatol. 2018 Jun;68(6):1286-1299. doi: 10.1016/j.jhep.2018.02.006. Epub 2018 Feb 20.

[Non-alcoholic fatty liver disease--What's new].

Dtsch Med Wochenschr. 2016 Apr;141(7):494-6. doi: 10.1055/s-0041-110215. Epub 2016 Mar 31.

Fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease?

Eur J Gastroenterol Hepatol. 2019 Jan;31(1):143. doi: 10.1097/MEG.0000000000001279.

Non-Alcoholic Fatty Liver Disease in HIV Infection.

AIDS Rev. 2017 Jan-Mar;19(1):35-46.

引用本文的文献

Exploring the Prevalence and Risk Factors of MASLD in Patients with Newly Diagnosed Diabetes Mellitus: A Comprehensive Investigation.

J Clin Med. 2025 May 17;14(10):3513. doi: 10.3390/jcm14103513.

Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study.

Open Med (Wars). 2025 Feb 19;20(1):20251154. doi: 10.1515/med-2025-1154. eCollection 2025.

The Role of microRNA-22 in Metabolism.

Int J Mol Sci. 2025 Jan 17;26(2):782. doi: 10.3390/ijms26020782.

MASLD, MLA Pesarattu and Other Developments.

J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102465. doi: 10.1016/j.jceh.2024.102465. Epub 2024 Nov 22.

Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.

Diabetes Metab J. 2024 Nov;48(6):1015-1028. doi: 10.4093/dmj.2024.0541. Epub 2024 Nov 21.

Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study.

Cancers (Basel). 2024 Sep 15;16(18):3161. doi: 10.3390/cancers16183161.

Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD).

J Clin Med. 2024 Aug 17;13(16):4857. doi: 10.3390/jcm13164857.

The effects of medicinal and food homologous substances on blood lipid and blood glucose levels and liver function in patients with nonalcoholic fatty liver disease: a systematic review of randomized controlled trials.

Lipids Health Dis. 2023 Aug 29;22(1):137. doi: 10.1186/s12944-023-01900-5.

Non-alcoholic fatty liver disease: Definition and subtypes.

Clin Mol Hepatol. 2023 Feb;29(suppl):S5-S16. doi: 10.3350/cmh.2022.0424. Epub 2022 Dec 28.

A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes.

Diagnostics (Basel). 2022 Oct 7;12(10):2426. doi: 10.3390/diagnostics12102426.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Redefining non-alcoholic fatty liver disease: what's in a name?

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献